These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 21983172)
1. UBR1 promotes protein kinase quality control and sensitizes cells to Hsp90 inhibition. Sultana R; Theodoraki MA; Caplan AJ Exp Cell Res; 2012 Jan; 318(1):53-60. PubMed ID: 21983172 [TBL] [Abstract][Full Text] [Related]
2. A network of ubiquitin ligases is important for the dynamics of misfolded protein aggregates in yeast. Theodoraki MA; Nillegoda NB; Saini J; Caplan AJ J Biol Chem; 2012 Jul; 287(28):23911-22. PubMed ID: 22593585 [TBL] [Abstract][Full Text] [Related]
3. Hsp90 rescues PTK6 from proteasomal degradation in breast cancer cells. Kang SA; Cho HS; Yoon JB; Chung IK; Lee ST Biochem J; 2012 Oct; 447(2):313-20. PubMed ID: 22849407 [TBL] [Abstract][Full Text] [Related]
4. Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors. Smith JR; Clarke PA; de Billy E; Workman P Oncogene; 2009 Jan; 28(2):157-69. PubMed ID: 18931700 [TBL] [Abstract][Full Text] [Related]
5. Specificity in the actions of the UBR1 ubiquitin ligase in the degradation of nuclear receptors. Sultana R; Theodoraki MA; Caplan AJ FEBS Open Bio; 2013; 3():394-7. PubMed ID: 24251101 [TBL] [Abstract][Full Text] [Related]
6. Phosphorylation accelerates geldanamycin-induced Akt degradation. Su CH; Lan KH; Li CP; Chao Y; Lin HC; Lee SD; Lee WP Arch Biochem Biophys; 2013 Aug; 536(1):6-11. PubMed ID: 23668972 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation. Yun BG; Matts RL Exp Cell Res; 2005 Jul; 307(1):212-23. PubMed ID: 15922741 [TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligase Cullin-5 modulates multiple molecular and cellular responses to heat shock protein 90 inhibition in human cancer cells. Samant RS; Clarke PA; Workman P Proc Natl Acad Sci U S A; 2014 May; 111(18):6834-9. PubMed ID: 24760825 [TBL] [Abstract][Full Text] [Related]
9. Associations of HSP90 client proteins in human breast cancer. Shipp C; Watson K; Jones GL Anticancer Res; 2011 Jun; 31(6):2095-101. PubMed ID: 21737627 [TBL] [Abstract][Full Text] [Related]
10. Akt shows variable sensitivity to an Hsp90 inhibitor depending on cell context. Theodoraki MA; Kunjappu M; Sternberg DW; Caplan AJ Exp Cell Res; 2007 Nov; 313(18):3851-8. PubMed ID: 17643429 [TBL] [Abstract][Full Text] [Related]
11. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells. Zhang Z; Li HM; Zhou C; Li Q; Ma L; Zhang Z; Sun Y; Wang L; Zhang X; Zhu B; Hong YS; Wu CZ; Liu H J Exp Clin Cancer Res; 2016 Sep; 35(1):149. PubMed ID: 27658586 [TBL] [Abstract][Full Text] [Related]
12. Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression. Schulz R; Marchenko ND; Holembowski L; Fingerle-Rowson G; Pesic M; Zender L; Dobbelstein M; Moll UM J Exp Med; 2012 Feb; 209(2):275-89. PubMed ID: 22271573 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of HSP90 activity negatively modulates myogenic differentiation and cell survival in C2C12 cells. Wagatsuma A; Shiozuka M; Kotake N; Takayuki K; Yusuke H; Mabuchi K; Matsuda R; Yamada S Mol Cell Biochem; 2011 Dec; 358(1-2):265-80. PubMed ID: 21739150 [TBL] [Abstract][Full Text] [Related]
14. Hsp90 inhibitor geldanamycin attenuates the cytotoxicity of sunitinib in cardiomyocytes via inhibition of the autophagy pathway. Kimura T; Uesugi M; Takase K; Miyamoto N; Sawada K Toxicol Appl Pharmacol; 2017 Aug; 329():282-292. PubMed ID: 28624441 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo. Schwock J; Pham NA; Cao MP; Hedley DW Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866 [TBL] [Abstract][Full Text] [Related]
16. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants. Prince TL; Kijima T; Tatokoro M; Lee S; Tsutsumi S; Yim K; Rivas C; Alarcon S; Schwartz H; Khamit-Kush K; Scroggins BT; Beebe K; Trepel JB; Neckers L PLoS One; 2015; 10(10):e0141786. PubMed ID: 26517842 [TBL] [Abstract][Full Text] [Related]
18. Distinct regulation of insulin receptor substrate-1 and -2 by 90-kDa heat-shock protein in adrenal chromaffin cells. Yoshikawa N; Nemoto T; Satoh S; Maruta T; Yanagita T; Chosa E; Wada A Neurochem Int; 2010 Jan; 56(1):42-50. PubMed ID: 19737590 [TBL] [Abstract][Full Text] [Related]
19. Design of novel Geldanamycin analogue hsp90 alpha-inhibitor in silico for breast cancer therapy. Mahanta S; Pilla S; Paul S Med Hypotheses; 2013 Sep; 81(3):463-9. PubMed ID: 23860250 [TBL] [Abstract][Full Text] [Related]
20. Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex. Stravopodis DJ; Margaritis LH; Voutsinas GE Curr Med Chem; 2007; 14(29):3122-38. PubMed ID: 18220746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]